Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Wardelmann

Showing results (141-150 of 248) with videos related to

Pageof 25
Sort By:
Biomed Research International|December 7, 2017
Neovascular Prostate-Specific Membrane Antigen Expression Is Associated with Improved Overall Survival under Palliative Chemotherapy in Patients with Pancreatic Ductal AdenocarcinomaKatharina Stock, Konrad Steinestel, Rebekka Wiesch, et al.
Surgery|June 29, 2024
Robotic-assisted esophagectomy with total mesoesophageal excision enhances R0-resection in patients with esophageal cancer: A single-center experienceJens P Hoelzen, Lukas Fortmann, Dhruvajyoti Roy, et al.
British Journal of Haematology|June 9, 2020
Low-density lipoprotein receptor (LDLR) is an independent adverse prognostic factor in acute myeloid leukaemiaMatthias Floeth, Sandra Elges, Joachim Gerss, et al.
Oncotarget|July 27, 2018
Diagnostic tools in the differential diagnosis of giant cell-rich lesions of bone at biopsyJan Rehkämper, Konrad Steinestel, Birte Jeiler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2016
Genomic EWSR1 Fusion Sequence as Highly Sensitive and Dynamic Plasma Tumor Marker in Ewing SarcomaManuela Krumbholz, Julia Hellberg, Benedikt Steif, et al.
Cancers|May 16, 2023
Radiomics of Tumor Heterogeneity in <sup>18</sup>F-FDG-PET-CT for Predicting Response to Immune Checkpoint Inhibition in Therapy-Naïve Patients with Advanced Non-Small-Cell Lung CancerDavid Ventura, Philipp Schindler, Max Masthoff, et al.
Annals of Hematology|March 21, 2015
Remissions of different quality following rituximab, tocilizumab and rituximab, and allogeneic stem cell transplantation in a patient with severe idiopathic multicentric Castleman's diseaseLinus Angenendt, Andrea Kerkhoff, Stefanie Wiebe, et al.
BMC Medical Genetics|July 6, 2010
Pitfalls in mutational testing and reporting of common KIT and PDGFRA mutations in gastrointestinal stromal tumorsSabine Merkelbach-Bruse, Wolfgang Dietmaier, Laszlo Füzesi, et al.
The American Journal of Surgical Pathology|September 25, 2013
Gastrointestinal stromal tumors with KIT exon 9 mutations: Update on genotype-phenotype correlation and validation of a high-resolution melting assay for mutational testingHelen Künstlinger, Sebastian Huss, Sabine Merkelbach-Bruse, et al.
Cancers|December 10, 2021
Multiparametric Magnetic Resonance Imaging for Immediate Target Hit Assessment of CD13-Targeted Tissue Factor tTF-NGR in Advanced Malignant DiseaseMirjam Gerwing, Tobias Krähling, Christoph Schliemann, et al.
Pageof 25

Showing results (141-150 of 248) with videos related to

Sort By:
Pageof 25
Biomed Research International|December 7, 2017
Neovascular Prostate-Specific Membrane Antigen Expression Is Associated with Improved Overall Survival under Palliative Chemotherapy in Patients with Pancreatic Ductal AdenocarcinomaKatharina Stock, Konrad Steinestel, Rebekka Wiesch, et al.
Surgery|June 29, 2024
Robotic-assisted esophagectomy with total mesoesophageal excision enhances R0-resection in patients with esophageal cancer: A single-center experienceJens P Hoelzen, Lukas Fortmann, Dhruvajyoti Roy, et al.
British Journal of Haematology|June 9, 2020
Low-density lipoprotein receptor (LDLR) is an independent adverse prognostic factor in acute myeloid leukaemiaMatthias Floeth, Sandra Elges, Joachim Gerss, et al.
Oncotarget|July 27, 2018
Diagnostic tools in the differential diagnosis of giant cell-rich lesions of bone at biopsyJan Rehkämper, Konrad Steinestel, Birte Jeiler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2016
Genomic EWSR1 Fusion Sequence as Highly Sensitive and Dynamic Plasma Tumor Marker in Ewing SarcomaManuela Krumbholz, Julia Hellberg, Benedikt Steif, et al.
Cancers|May 16, 2023
Radiomics of Tumor Heterogeneity in <sup>18</sup>F-FDG-PET-CT for Predicting Response to Immune Checkpoint Inhibition in Therapy-Naïve Patients with Advanced Non-Small-Cell Lung CancerDavid Ventura, Philipp Schindler, Max Masthoff, et al.
Annals of Hematology|March 21, 2015
Remissions of different quality following rituximab, tocilizumab and rituximab, and allogeneic stem cell transplantation in a patient with severe idiopathic multicentric Castleman's diseaseLinus Angenendt, Andrea Kerkhoff, Stefanie Wiebe, et al.
BMC Medical Genetics|July 6, 2010
Pitfalls in mutational testing and reporting of common KIT and PDGFRA mutations in gastrointestinal stromal tumorsSabine Merkelbach-Bruse, Wolfgang Dietmaier, Laszlo Füzesi, et al.
The American Journal of Surgical Pathology|September 25, 2013
Gastrointestinal stromal tumors with KIT exon 9 mutations: Update on genotype-phenotype correlation and validation of a high-resolution melting assay for mutational testingHelen Künstlinger, Sebastian Huss, Sabine Merkelbach-Bruse, et al.
Cancers|December 10, 2021
Multiparametric Magnetic Resonance Imaging for Immediate Target Hit Assessment of CD13-Targeted Tissue Factor tTF-NGR in Advanced Malignant DiseaseMirjam Gerwing, Tobias Krähling, Christoph Schliemann, et al.
Pageof 25